STCOSD
EBS icon

Sageworth Trust Company of South Dakota’s Emergent Biosolutions EBS Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26
Closed -$1K – 355
2022
Q2 		$1K Hold
26
– – ﹤0.01% 462
2022
Q1 		$1K Sell
26
-123
-83% -$5.42K ﹤0.01% 498
2021
Q4 		$6K Buy
+149
New +$6.74K 0.01% 484

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Sageworth Trust Company of South Dakota's EBS Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 26 shares — an estimated $1K sold.

Sageworth Trust Company of South Dakota first reported a position in EBS in Q4 2021 and held it in 3 quarters. The position peaked at $6K in Q4 2021. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 26 Emergent Biosolutions shares in Q3 2022, an estimated $1K.
  • Sageworth Trust Company of South Dakota first reported a position in Emergent Biosolutions in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Emergent Biosolutions position peaked at $6K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.